Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Leukemia 186Lymphoma 137Leukemia, Myeloid, Acute 103Burkitt Lymphoma 91Myelodysplastic Syndromes 79Lymphoma, Non-Hodgkin 65Breast Neoplasms 60Lymphoma, Large B-Cell, Diffuse 59Leukemia, Lymphocytic, Chronic, B-Cell 49Lymphoma, Mantle-Cell 47Hodgkin Disease 47Graft vs Host Disease 46Lymphoma, Follicular 45Leukemia, Myeloid, Accelerated Phase 45Multiple Myeloma 39Leukemia, Myeloid, Chronic-Phase 39Congenital Abnormalities 39Myeloproliferative Disorders 38Blast Crisis 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Biphenotypic, Acute 36Recurrence 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, B-Cell, Marginal Zone 31Osteosarcoma 29Primary Myelofibrosis 27Neoplasms, Plasma Cell 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25

Interventions

Paclitaxel 328Carboplatin 323Bevacizumab 171Gemcitabine 106liposomal doxorubicin 104pembrolizumab 101Cyclophosphamide 96Topotecan 94olaparib 92Cisplatin 92niraparib 69Docetaxel 57Taxes 52Doxorubicin 51Drug Therapy 45fludarabine 40Filgrastim 39Nivolumab 37Magnetic Resonance Spectroscopy 34Surveys and Questionnaires 33Specimen Handling 33Etoposide 32Hyperthermic Intraperitoneal Chemotherapy 31Blood Specimen Collection 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Cytoreduction Surgical Procedures 25Albumin-Bound Paclitaxel 25durvalumab 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Methotrexate × Clear all
NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed
74 enrolled 13 charts
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT01175772 2015-06-23

Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy

HaEmek Medical Center, Israel

Phase 2 Terminated
6 enrolled
Gynecologic

Carcinoma, Ovarian Neoplasms

NCT00002487 2013-09-17

Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00002489 2013-06-26

Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gynecologic

Teratoma, Ovarian, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡